Jesse M. Cedarbaum

Jesse M. Cedarbaum is a Venture Advisor at Israel Biotech Fund. Dr. Cedarbaum obtained his medical degree from Yale Medical School, where he is currently Professor (Adjunct) of Psychiatry. Dr. Cedarbaum led the Parkinson and Movement Disorders Program at Burke Rehabilitation Center and the New York Hospital.

Dr. Cedarbaum then joined Regeneron, where he led the establishment of the clinical development function and served as Program Director and later Vice President of Clinical Affairs. He subsequently held positions at Elan, Cytokinetics, and Bristol-Myers Squib and most recently as Sr. Distinguished Investigator at Biogen, leading a team focused on the development of novel therapeutics for Parkinson’s disease and Movement Disorders. Dr. Cedarbaum has authored or co-authored over 100 peer-reviewed scientific publications, most in the area of neurotherapeutics.